Refractory Ulcerative Colitis

Refractory Ulcerative Colitis is a clinical phenotype of ulcerative colitis characterized by inadequate response to standard first-line pharmacological therapies, including corticosteroids and conventional immunosuppressants, despite optimal dosing and adherence.

867

Publications

60.7K

Citations

5K

Authors

1.4K

Institutions

Publications per year

2017–2026

252

Authors

5K

  1. WJ
    William J. Sandborn

    University of California San Diego, United States

    27 publications · 7.5K citations

    21

    h-index

  2. GV
    Gert Van Assche

    KU Leuven, Belgium

    20 publications · 2.9K citations

    18

    h-index

  3. LP
    Laurent Peyrin‐Biroulet

    Inserm, France

    18 publications · 1.5K citations

    15

    h-index

  4. PG
    Paolo Gionchetti

    University of Bologna, Italy

    15 publications · 4.7K citations

    15

    h-index

  5. BS
    Bo Shen

    Cleveland Clinic, United States

    17 publications · 1.6K citations

    14

    h-index

1–5 of 5K

Venues

  1. Inflammatory Bowel Diseases

    79 publications · 5.5K citations

    44

    h-index

  2. Alimentary Pharmacology & Therapeutics

    61 publications · 4.6K citations

    43

    h-index

  3. Journal of Crohn s and Colitis

    JCC · 58 publications · 7.6K citations

    35

    h-index

  4. PubMed

    Repository · 67 publications · 3.1K citations

    30

    h-index

  5. The American Journal of Gastroenterology

    AJG · 34 publications · 4K citations

    27

    h-index

1–5